EGFR and non-small cell lung carcinoma: Mutation of the EGFR signaling pathway has been implicated in the development of NSCLC [15,16]; indeed, several studies have classified NSCLC into two distinct categories: EGFR-mutated and EGFR-wild type NSCLC [12,14].